Page 25 - Pharmaceutical- Guide to Biopharmaceutical
P. 25

Characterization  Quality Control


 Analysis of Product Peptide Fragments  LC-2060 Series





 Using Integrated UHPLC System with High   benefits

 Repeatability for Mapping Peptides in Antibody Drugs                                                              Cell Line Optimization
 click here            •   Easy-access, front-panel interface ensures easy operation, even when wearing gloves.
                       •   Can be connected to a mass spectrometer.
 Operating Principle and Features
 10 mg/mL Human IgG in water 20 µL   •   Provides data with high repeatability.
 Using  HPLC  for  peptide  mapping  requires  a  system  with  high   6 mol/L Guanidine hydrochloride in
 repeatability, because the analysis involves comparing elution profiles   0.25 mol/L Tris buffer (pH 7.5) 80 µL
 to confirm whether peptides are identical or have mutations. LC-2060   0.5 mol/L Dithiothreitol in water 2 µL     Culture
 series integrated UHPLC systems are ideal for such analysis.
 Incubate at 37 ˚C for 30 min
 Measurement Method and Conditions  0.5 mol/L Iodoacetamide in water 4.8 µL


 Samples were prepared by reduction, alkylation, and then trypsin   Incubate at room temperature for 30 min in the dark
 enzyme digestion of human immunoglobulin G (IgG) (Fig. 1) and   0.5 mol/L Dithiothreitol in water 2 µL
 analyzed according to the analytical conditions in Table 1.
 0.25 mol/L Tris buffer (pH 7.5) 700 µL
 Results  1 mg/mL Trypsin in 1 mmol/L HCl 4 µL

 The chromatogram from the trypsin-digested IgG shows that an   Incubate at 37 ˚C for 20 hours                     Purification
 extremely large number of peaks are detected and separated (Fig.   Tri uoroacetic acid 1 µL
 2). For peptide mapping, an extremely long gradual gradient is used   Inject to UHPLC
 to separate the many peaks. Consequently, results tend to have
 poor repeatability, especially if using a low-pressure gradient system.   Fig. 1   Pretreatment Process Flow
 Therefore, the intra-day and inter-day repeatability were also checked.   4.5  mAU (×10)
 Key peaks (a to f) were selected from the chromatogram. Intra-day
 repeatability was calculated from six consecutive analysis results. Inter-  4.0
 day repeatability was calculated from the daily average values of three
 analyses on each of six days (Tables 2 and 3). Both the intra-day and   3.5
 inter-day repeatability values indicated good reproducibility.                                                    Characterization
 3.0           Specifications
 Table 1   Analytical Conditions
 2.5
 Column:  Aeris PEPTIDE XB-C18 100 Å  Instrument  LC-2060 series
 (150 mm × 2.0 mm I.D., 1.7 μm)
 Mobile phase A:  0.1 % Trifluoroacetic acid in water  2.0  Degassing unit  Five Lines: Mobile phase 4 + Rinse solution 1
 Mobile phase B:  0.08 % Trifluoroacetic acid in acetonitrile  Pumping method  Parallel-type double plunger
 Time Program:  0 % (0 min) → 45 % (90 min) →  1.5
  (B. Conc.)  → 100 % (90.01 – 95 min) →  Pulsation  Max. 0.1 MPa (1.0 mL/min, 10 MPa, Water)
 → 0 % (95.01 – 110 min)  1.0
 Flowrate:  0.2 mL/min  Flowrate setting range  0.0001 to 10 mL/min
 Column Temp.:  60 °C  0.5  Configuration  Four-solvent low-pressure gradient                                      Quality Control
 Injection Volume:  10 µL
 Detection:  PDA (215 nm)  0.0  Gradient settings  0 to 100 %, in 0.1 % steps
 Flow Cell:  High-speed high-sensitivity cell
 0.0  25.0  50.0  75.0 min  Maximum pressure  70 MPa  0.0001 to 3 mL/min
 Fig. 2   Chromatogram of IgG Trypsin Digestion Products
 Conclusion  Table 2   Intra-day Repeatability of Retention Times (n = 6)  System delay volume  460 µL
    Peak  Avg. R.T. (min)  Std. Dev. (min)  %RSD (%)  Autosampler
 LC-2060 series systems provide data with excellent repeatability even   Peak a  9.929  0.027  0.271  Injection method  Total-volume sample injection
 when using analytical conditions prone to cause poor repeatability in   Peak b  24.669  0.047  0.192
 low-pressure gradient systems. They can also be connected to a mass   Peak c  36.299  0.042  0.117  Injection volume setting range  0.1 to 50 μL (Option: 0.1 to 100 μL, 1 to 500 μL, 1 to 2,000 μL)
 spectrometer for peptide mapping.  Peak d  48.815  0.033  0.068  Injection cycle time  Min. 14 sec (Specified condition)  Pharmacokinetics
 Peak e  59.864  0.032  0.054
 Application Examples   Peak f  74.535  0.043  0.057  Samples for processing  336 vials (1 mL), 216 vials (1.5 mL), 112 vials (4 mL), 4 sample plates
               Sample cooler          4 to 45 °C
 • High-sensitivity analysis using a fluorescence detector  Table 3   Intra-day Repeatability of Retention Times (n = 6)  Column oven
 • Various UHPLC analyses  Peak  Avg. R.T. (min)  Std. Dev. (min)  %RSD (%)
 Peak a  9.907  0.016  0.159  Heating and cooling method  Forced air circulation method
 Peak b  24.708  0.033  0.132
               Containable column size  6 columns 10 cm long and 3 columns 30 cm long                              Others
 Peak c  36.355  0.034  0.093
 Peak d  48.877  0.034  0.093  Temperature control range  Room temperature - 12 to 90 °C, Setting range 4 to 90 °C
 Peak e  59.901  0.027  0.046
 Peak f  74.555  0.036  0.049  Flowrate switching valve  Max. 1 pc


 24                                                                                                               25
 index                                                                                                   index
   20   21   22   23   24   25   26   27   28   29   30